•
Sep 30, 2021
Ryan Specialty Group Q3 2021 Earnings Report
Ryan Specialty Group's financial performance was strong, marked by substantial revenue growth and strategic advancements.
Key Takeaways
Ryan Specialty Group reported a 49.0% increase in total revenue to $352.8 million. The company's organic revenue growth rate was 28.9%. A net loss of $32.6 million was reported, influenced by $58.6 million in one-time IPO-related costs. Adjusted net income increased by 51.1% to $62.9 million.
Total revenue increased by 49.0% year-over-year, reaching $352.8 million.
Organic revenue growth rate was 28.9% for the quarter.
Net loss was $32.6 million, including $58.6 million of one-time IPO costs.
Adjusted net income grew by 51.1% to $62.9 million.
Ryan Specialty Group
Ryan Specialty Group
Ryan Specialty Group Revenue by Segment
Forward Guidance
The Company is raising its full year 2021 outlook for both Organic Revenue Growth Rate and Adjusted EBITDAC Margin
Positive Outlook
- Organic Revenue Growth Rate for full year 2021 is now expected to be between 21.5% - 22.5%, compared to the Company’s prior outlook of between 18.0% - 20.0%.
- Adjusted EBITDAC Margin for full year 2021 is now expected to be between 31.5% - 32.0%, compared to the Company’s prior outlook of between 30.0% - 30.5%.
- The company is raising its full year 2021 outlook for both Organic Revenue Growth Rate and Adjusted EBITDAC Margin
- Organic Revenue Growth Rate for full year 2021 is now expected to be between 21.5% - 22.5%.
- Adjusted EBITDAC Margin for full year 2021 is now expected to be between 31.5% - 32.0%.